Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem
- PMID: 24747701
- PMCID: PMC4814932
- DOI: 10.1038/ni.2853
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem
Abstract
Live and live-attenuated whole organism vaccines against Plasmodium falciparum malaria and cutaneous leishmaniasis due to Leishmania major remain the most uniformly effective vaccines against human parasitic diseases. These vaccines are discussed in terms of the nature of the T cell populations that mediate the strong and durable localized immunity to these infections, and the requirement for persisting antigen to generate and maintain the protective response. The difficulties in developing subunit vaccines that fulfill this requirement argue that despite their own formidable problems in manufacture and delivery, live and live- attenuated whole organism vaccines against human parasitic diseases should be vigorously pursued.
References
-
- Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME. 2013;162(3):144–155. - PubMed
-
- Hotez PJ, Ferris MT. Vaccine. 2006;24(31–32):5787–5799. - PubMed
-
- Sacks DL, Sher A, Riley EM, Wynn TA. In: Fundamental Immunology. sixth. Paul WE, editor. Lippincott, Williams & Wilkins; Philadelphia: 2008.
-
- Clyde DF, Most H, McCarthy VC, Vanderberg JP. The American journal of the medical sciences. 1973;266(3):169–177. - PubMed
-
- Nussenzweig RS, Vanderberg J, Most H, Orton C. Nature. 1967;216(5111):160–162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
